Operating numbers were very strong as earnings before interest, tax, depreciation and amortisation (EBITDA) surged 44 percent YoY to Rs 163.15 crore and margin expanded to 23.17 percent (from 17.93 percent) in Q3.
Net Sales are expected to increase by 13 percent Y-o-Y (up 10.3 percent Q-o-Q) to Rs. 656.4 crore, according to Emkay.
Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities.
Emkay Global, in its report, observed that cycling pressure in US market will start waning ahead, but structural pressures will still persist.
Net Sales are expected to increase by 21.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 432.7 crore, according to KR Choksey.
Net Sales are expected to increase by 16.5 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs. 410 crore, according to HDFC Securities.
Granules India's second quarter earnings were more or less inline or a tad bit lower than what the street was working with but their overall performance has been largely in-line.
Net Sales are expected to increase by 4 percent Q-o-Q (up 7.57 percent Y-o-Y) to Rs 369.5 crore, according to KR Choksey. Granules India to report net profit at 37.2 crore up 16.61% year-on-year.
Net Sales are expected to increase by 3.8 percent Q-o-Q (up 9.5 percent Y-o-Y) to Rs 377.6 crore, according to KR Choksey.
Granules India is looking at expanding its business to new geographies. The company is targeting 30-40 percent bottomline growth in FY18, C Krishna Prasad, MD of company said.
Net Sales are expected to increase by 16.2 percent Q-o-Q (up 9 percent Y-o-Y) to Rs 399.3 crore, according to Centrum.
C Krishna Prasad, MD of Granules India expects a 15 percent revenue growth in Q4 and 15-20 percent rise in FY17.
Harsha Chigurupati, director, Granules India, says that last year the company reported a major increase in profit due to forex gains of around Rs 8 crore. This year too, the company performed better than previous year. There has been improvement in revenues and the company expects revenues to grow at 30 percent in FY14.
C Krishna Prasad, MD, Granules India, spoke to CNBC-TV 18 about the company's performance and what to expect in the days to come.